Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)
This study has been completed.
Information provided by (Responsible Party):
Notal Vision Ltd
First received: January 8, 2008
Last updated: April 13, 2015
Last verified: April 2015
Demonstrate the ability of the current interactive tutorial and 1-800 support to teach an AMD patient to use the HMP device.
Age Related Macular Degeneration
||Observational Model: Cohort
Time Perspective: Prospective
||Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) in Intermediate Age Related Macular Degeneration Patients
Primary Outcome Measures:
- Proportion of subjects who manage to use the device as in a daily testing [ Time Frame: 1 month ] [ Designated as safety issue: No ]
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||April 2008 (Final data collection date for primary outcome measure)
Intermediate AMD Patients
The pilot study purpose is to demonstrate that the tutorial which is a part of the device software, is giving sufficient training for the intended users.
|Ages Eligible for Study:
||50 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Subjects diagnosed as intermediate AMD in at least one eye
- Capable and willing to sign a consent form and participate in the study
- Subjects diagnosed as intermediate AMD in at least one eye
- Age >50 years
- VA with habitual correction >20/60 in the study eye
- Ability to speak, read and understand instructions in Hebrew
- Familiar with computer usage
- Evidence of macular disease other than AMD or glaucoma in the study eye
- Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy, CFP.
- Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye
- Participation in another study with the exclusion of AREDS study
- Patients diagnosed with geographic atrophy (GA)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00603850
|Charlotte Eye Ear Nose & Throat
|Charlotte, North Carolina, United States, 28210 |
Notal Vision Ltd
||Justin Mr Brown, MD
||Charlotte Eye Ear Nose & Throat
No publications provided
||Notal Vision Ltd
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 8, 2008
||April 13, 2015
||United States: Institutional Review Board
Keywords provided by Notal Vision Ltd:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 27, 2015